Tenax Therapeutics, Inc. (TENX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$2.3K
Year ended 2022-12-31
-13.4%
3-year compound annual growth
-12.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $2.3K | -55.8% | 2023-03-31, From 2022-01-01 |
| 2021-12-31 | $5.3K | +50.5% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $3.5K | -2.4% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $3.6K | -52.9% | 2021-04-16, From 2019-01-01 |
| 2018-12-31 | $7.6K | +67.4% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $4.5K | +57.3% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $2.9K | n/a | 2018-04-02, From 2016-01-01 |
| No annual figure between 2015-04-30 and 2016-12-31. | |||
| 2015-04-30 | $4.2K | -56.8% | 2017-03-16, From 2014-05-01 |
| 2014-04-30 | $9.8K | -43.0% | 2017-03-16, From 2013-05-01 |
| 2013-04-30 | $17.2K | -2.6% | 2014-07-29, From 2012-05-01 |
| 2012-04-30 | $17.7K | -92.7% | 2013-06-26, From 2011-05-01 |
| 2011-04-30 | $240.8K | n/a | 2012-07-25, From 2010-05-01 |